Lymphocytic colitis: Clinical features, treatment, and outcomes

Darrell S. Pardi, Venktesh R. Ramnath, Edward Vincent Loftus, Jr, William J. Tremaine, William J. Sandborn

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

OBJECTIVE: There are no reports of the clinical features or treatment outcomes in large series of patients with lymphocytic colitis, and it is not known whether treatments that appear to be beneficial in patients with collagenous colitis are also beneficial in lymphocytic colitis. We sought to analyze these issues in our patients with lymphocytic colitis. METHODS: All patients with biopsy-proven lymphocytic colitis evaluated at our institution between January 1, 1997, and December 31, 1999, were identified. Clinical features on presentation and treatment outcomes were abstracted from the medical records. RESULTS: A total of 170 patients with lymphocytic colitis were identified (median age 67 yr, 61% female). Diarrhea, bloating, rectal urgency, fecal incontinence, weight loss, concomitant autoimmune disorders, and aspirin or nonsteroidal anti-inflammatory drug use were common. Loperamide, diphenoxylate/atropine, and bismuth subsalicylate were effective therapies and were well tolerated. However, no therapy produced a complete response in more than 40% of patients. CONCLUSIONS: Lymphocytic colitis typically presents in elderly patients as chronic diarrhea. Nocturnal stools, urgency, and abdominal pain occur frequently, as do weight loss, fecal incontinence, and concomitant autoimmune disorders. Many empiric treatment options are used, but overall response rates are disappointing. Randomized controlled trials are needed to determine the optimum therapeutic approach to these patients.

Original languageEnglish (US)
Pages (from-to)2829-2833
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume97
Issue number11
StatePublished - Nov 1 2002

Fingerprint

Lymphocytic Colitis
Fecal Incontinence
Weight Loss
Diarrhea
Diphenoxylate
Collagenous Colitis
Loperamide
Therapeutics
Atropine
Abdominal Pain
Aspirin
Medical Records
Anti-Inflammatory Agents
Randomized Controlled Trials
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Pardi, D. S., Ramnath, V. R., Loftus, Jr, E. V., Tremaine, W. J., & Sandborn, W. J. (2002). Lymphocytic colitis: Clinical features, treatment, and outcomes. American Journal of Gastroenterology, 97(11), 2829-2833.

Lymphocytic colitis : Clinical features, treatment, and outcomes. / Pardi, Darrell S.; Ramnath, Venktesh R.; Loftus, Jr, Edward Vincent; Tremaine, William J.; Sandborn, William J.

In: American Journal of Gastroenterology, Vol. 97, No. 11, 01.11.2002, p. 2829-2833.

Research output: Contribution to journalArticle

Pardi, DS, Ramnath, VR, Loftus, Jr, EV, Tremaine, WJ & Sandborn, WJ 2002, 'Lymphocytic colitis: Clinical features, treatment, and outcomes', American Journal of Gastroenterology, vol. 97, no. 11, pp. 2829-2833.
Pardi DS, Ramnath VR, Loftus, Jr EV, Tremaine WJ, Sandborn WJ. Lymphocytic colitis: Clinical features, treatment, and outcomes. American Journal of Gastroenterology. 2002 Nov 1;97(11):2829-2833.
Pardi, Darrell S. ; Ramnath, Venktesh R. ; Loftus, Jr, Edward Vincent ; Tremaine, William J. ; Sandborn, William J. / Lymphocytic colitis : Clinical features, treatment, and outcomes. In: American Journal of Gastroenterology. 2002 ; Vol. 97, No. 11. pp. 2829-2833.
@article{94b268c3141144b18587bc48c0ab75a7,
title = "Lymphocytic colitis: Clinical features, treatment, and outcomes",
abstract = "OBJECTIVE: There are no reports of the clinical features or treatment outcomes in large series of patients with lymphocytic colitis, and it is not known whether treatments that appear to be beneficial in patients with collagenous colitis are also beneficial in lymphocytic colitis. We sought to analyze these issues in our patients with lymphocytic colitis. METHODS: All patients with biopsy-proven lymphocytic colitis evaluated at our institution between January 1, 1997, and December 31, 1999, were identified. Clinical features on presentation and treatment outcomes were abstracted from the medical records. RESULTS: A total of 170 patients with lymphocytic colitis were identified (median age 67 yr, 61{\%} female). Diarrhea, bloating, rectal urgency, fecal incontinence, weight loss, concomitant autoimmune disorders, and aspirin or nonsteroidal anti-inflammatory drug use were common. Loperamide, diphenoxylate/atropine, and bismuth subsalicylate were effective therapies and were well tolerated. However, no therapy produced a complete response in more than 40{\%} of patients. CONCLUSIONS: Lymphocytic colitis typically presents in elderly patients as chronic diarrhea. Nocturnal stools, urgency, and abdominal pain occur frequently, as do weight loss, fecal incontinence, and concomitant autoimmune disorders. Many empiric treatment options are used, but overall response rates are disappointing. Randomized controlled trials are needed to determine the optimum therapeutic approach to these patients.",
author = "Pardi, {Darrell S.} and Ramnath, {Venktesh R.} and {Loftus, Jr}, {Edward Vincent} and Tremaine, {William J.} and Sandborn, {William J.}",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "97",
pages = "2829--2833",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Lymphocytic colitis

T2 - Clinical features, treatment, and outcomes

AU - Pardi, Darrell S.

AU - Ramnath, Venktesh R.

AU - Loftus, Jr, Edward Vincent

AU - Tremaine, William J.

AU - Sandborn, William J.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - OBJECTIVE: There are no reports of the clinical features or treatment outcomes in large series of patients with lymphocytic colitis, and it is not known whether treatments that appear to be beneficial in patients with collagenous colitis are also beneficial in lymphocytic colitis. We sought to analyze these issues in our patients with lymphocytic colitis. METHODS: All patients with biopsy-proven lymphocytic colitis evaluated at our institution between January 1, 1997, and December 31, 1999, were identified. Clinical features on presentation and treatment outcomes were abstracted from the medical records. RESULTS: A total of 170 patients with lymphocytic colitis were identified (median age 67 yr, 61% female). Diarrhea, bloating, rectal urgency, fecal incontinence, weight loss, concomitant autoimmune disorders, and aspirin or nonsteroidal anti-inflammatory drug use were common. Loperamide, diphenoxylate/atropine, and bismuth subsalicylate were effective therapies and were well tolerated. However, no therapy produced a complete response in more than 40% of patients. CONCLUSIONS: Lymphocytic colitis typically presents in elderly patients as chronic diarrhea. Nocturnal stools, urgency, and abdominal pain occur frequently, as do weight loss, fecal incontinence, and concomitant autoimmune disorders. Many empiric treatment options are used, but overall response rates are disappointing. Randomized controlled trials are needed to determine the optimum therapeutic approach to these patients.

AB - OBJECTIVE: There are no reports of the clinical features or treatment outcomes in large series of patients with lymphocytic colitis, and it is not known whether treatments that appear to be beneficial in patients with collagenous colitis are also beneficial in lymphocytic colitis. We sought to analyze these issues in our patients with lymphocytic colitis. METHODS: All patients with biopsy-proven lymphocytic colitis evaluated at our institution between January 1, 1997, and December 31, 1999, were identified. Clinical features on presentation and treatment outcomes were abstracted from the medical records. RESULTS: A total of 170 patients with lymphocytic colitis were identified (median age 67 yr, 61% female). Diarrhea, bloating, rectal urgency, fecal incontinence, weight loss, concomitant autoimmune disorders, and aspirin or nonsteroidal anti-inflammatory drug use were common. Loperamide, diphenoxylate/atropine, and bismuth subsalicylate were effective therapies and were well tolerated. However, no therapy produced a complete response in more than 40% of patients. CONCLUSIONS: Lymphocytic colitis typically presents in elderly patients as chronic diarrhea. Nocturnal stools, urgency, and abdominal pain occur frequently, as do weight loss, fecal incontinence, and concomitant autoimmune disorders. Many empiric treatment options are used, but overall response rates are disappointing. Randomized controlled trials are needed to determine the optimum therapeutic approach to these patients.

UR - http://www.scopus.com/inward/record.url?scp=0036840889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840889&partnerID=8YFLogxK

M3 - Article

C2 - 12425555

AN - SCOPUS:0036840889

VL - 97

SP - 2829

EP - 2833

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 11

ER -